CN101415437A - 用于家禽疫苗接种的干粉组合物和系统 - Google Patents

用于家禽疫苗接种的干粉组合物和系统 Download PDF

Info

Publication number
CN101415437A
CN101415437A CNA2007800089704A CN200780008970A CN101415437A CN 101415437 A CN101415437 A CN 101415437A CN A2007800089704 A CNA2007800089704 A CN A2007800089704A CN 200780008970 A CN200780008970 A CN 200780008970A CN 101415437 A CN101415437 A CN 101415437A
Authority
CN
China
Prior art keywords
virus
vaccination
dry powder
poultry
powder composite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800089704A
Other languages
English (en)
Chinese (zh)
Inventor
J·P·莱蒙
C·弗瓦特
E·科巴涅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ghent University
Original Assignee
Ghent University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ghent University filed Critical Ghent University
Publication of CN101415437A publication Critical patent/CN101415437A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
CNA2007800089704A 2006-03-15 2007-03-15 用于家禽疫苗接种的干粉组合物和系统 Pending CN101415437A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06005245.3 2006-03-15
EP06005245A EP1834651A1 (en) 2006-03-15 2006-03-15 Compositions and methods for veterinary vaccination

Publications (1)

Publication Number Publication Date
CN101415437A true CN101415437A (zh) 2009-04-22

Family

ID=37564170

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800089704A Pending CN101415437A (zh) 2006-03-15 2007-03-15 用于家禽疫苗接种的干粉组合物和系统

Country Status (14)

Country Link
US (2) US20090041852A1 (enExample)
EP (2) EP1834651A1 (enExample)
JP (1) JP2009529558A (enExample)
CN (1) CN101415437A (enExample)
BR (1) BRPI0708983A2 (enExample)
DK (1) DK1993605T3 (enExample)
ES (1) ES2389864T3 (enExample)
MX (1) MX2008011701A (enExample)
PL (1) PL1993605T3 (enExample)
PT (1) PT1993605E (enExample)
RU (1) RU2450828C2 (enExample)
SI (1) SI1993605T1 (enExample)
UA (1) UA96754C2 (enExample)
WO (1) WO2007104562A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103083659A (zh) * 2013-01-18 2013-05-08 北京华夏兴洋生物科技有限公司 新型无油佐剂制备方法及用途
CN109260467A (zh) * 2018-08-17 2019-01-25 山东信得科技股份有限公司 一种预防雏鹅痛风症状的疫苗
CN113599513A (zh) * 2020-10-23 2021-11-05 青岛大学 一种适用于咽喉部接种的新型冠状病毒疫苗的制备方法及接种方法

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1834651A1 (en) * 2006-03-15 2007-09-19 Universiteit Gent Compositions and methods for veterinary vaccination
ES2661038T3 (es) * 2008-03-24 2018-03-27 Intervet International B.V. Vacunas encapsuladas para la vacunación oral y de refuerzo de peces y otros animales
US8778384B2 (en) 2008-03-24 2014-07-15 Advanced Bionutrition Corporation Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
WO2010037027A2 (en) * 2008-09-26 2010-04-01 Auburn University Immunization of avians by mucosal administration of non-replicating vectored vaccines
ES2661215T3 (es) 2009-05-20 2018-03-28 Aeras Composiciones víricas; inmunógenas; secadas por pulverización; estables
JP5550277B2 (ja) * 2009-07-23 2014-07-16 長谷川香料株式会社 保存安定性に優れた粉末組成物
KR101745029B1 (ko) * 2009-08-21 2017-06-08 메리얼 인코포레이티드 재조합 조류 파라믹소바이러스 백신 및 이의 제조 및 사용 방법
WO2011041788A2 (en) * 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Turkey viral hepatitis virus and uses thereof
CN102772799A (zh) * 2012-05-31 2012-11-14 郑州后羿制药有限公司 一种鸭病毒性肝炎、鸭瘟二联卵黄抗体冻干粉及其制备方法
EP3512939B1 (en) 2016-09-16 2026-06-17 Leukocare AG A novel method for obtaining efficient viral vector-based compositions for vaccination or gene therapy
US11510871B2 (en) 2016-09-16 2022-11-29 Leukocare Ag Method for producing low viscous and highly concentrated biopharmaceutical drug products in liquid formulation
CN107019707A (zh) * 2017-03-14 2017-08-08 杨凌绿方生物工程有限公司 一种鸡胚成纤维细胞产品冻干工艺方法
TR201718859A2 (tr) * 2017-11-27 2017-12-21 Bilge Kaan Tekelioglu Siğirlarin gangrenli̇ nezlesi̇ i̇çi̇n aşi ve aşinin üreti̇m yöntemi̇
EP3698773A1 (en) 2019-02-21 2020-08-26 Università degli Studi di Parma Composition and manufacturing of powders containing nanoadjuvants for mucosal vaccination
IL313015A (en) * 2021-11-25 2024-07-01 Orexo Ab A pharmaceutical preparation that includes biopharmaceutical drug compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58105310U (ja) * 1982-01-11 1983-07-18 貝原　睦衛 ひよこ用ワクチン点眼装置
JPS5924019U (ja) * 1982-08-05 1984-02-15 イカリ消毒株式会社 動物用ワクチン投与装置
RU2035909C1 (ru) * 1993-06-02 1995-05-27 Виноходов Владимир Олегович Препарат для профилактики и лечения заболеваний птиц
GB9607035D0 (en) * 1996-04-03 1996-06-05 Andaris Ltd Spray-dried microparticles as therapeutic vehicles
SE9801288D0 (sv) * 1998-04-14 1998-04-14 Astra Ab Vaccine delivery system and metod of production
US6651655B1 (en) * 2000-01-18 2003-11-25 Quadrant Technologies Limited Inhaled vaccines
WO2005123131A2 (en) * 2004-06-14 2005-12-29 Medimmune Vaccines, Inc. High pressure spray-dry of bioactive materials
JP2006512102A (ja) * 2002-04-11 2006-04-13 メディミューン・ヴァクシンズ・インコーポレーテッド 噴霧乾燥による生物活性材料の防腐
AU2002951692A0 (en) * 2002-09-23 2002-10-17 Vital Biotech (Hong Kong) Limited Improvements in or relating to vaccines
KR20050088175A (ko) * 2002-12-17 2005-09-02 메드이뮨 백신즈 인코포레이티드 생물활성 물질의 고압 분무 건조
US20050207983A1 (en) * 2004-03-05 2005-09-22 Pulmatrix, Inc. Formulations decreasing particle exhalation
EP1834651A1 (en) * 2006-03-15 2007-09-19 Universiteit Gent Compositions and methods for veterinary vaccination

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103083659A (zh) * 2013-01-18 2013-05-08 北京华夏兴洋生物科技有限公司 新型无油佐剂制备方法及用途
CN109260467A (zh) * 2018-08-17 2019-01-25 山东信得科技股份有限公司 一种预防雏鹅痛风症状的疫苗
CN109260467B (zh) * 2018-08-17 2021-08-20 山东信得科技股份有限公司 一种预防雏鹅痛风症状的疫苗
CN113599513A (zh) * 2020-10-23 2021-11-05 青岛大学 一种适用于咽喉部接种的新型冠状病毒疫苗的制备方法及接种方法

Also Published As

Publication number Publication date
WO2007104562A1 (en) 2007-09-20
SI1993605T1 (sl) 2012-11-30
US20090041852A1 (en) 2009-02-12
RU2008140745A (ru) 2010-04-20
US20110150940A1 (en) 2011-06-23
BRPI0708983A2 (pt) 2011-06-21
MX2008011701A (es) 2008-11-27
EP1993605B1 (en) 2012-06-27
PL1993605T3 (pl) 2012-12-31
ES2389864T3 (es) 2012-11-02
PT1993605E (pt) 2012-09-17
JP2009529558A (ja) 2009-08-20
DK1993605T3 (da) 2012-09-10
UA96754C2 (ru) 2011-12-12
EP1993605A1 (en) 2008-11-26
RU2450828C2 (ru) 2012-05-20
EP1834651A1 (en) 2007-09-19

Similar Documents

Publication Publication Date Title
EP1993605B1 (en) Dry powder compositions and systems for poultry vaccination
US10159644B2 (en) Inhalable vaccine compositions and methods
RU2339400C2 (ru) Стабилизированная вакцинная композиция для стимулирования иммунного ответа и способ ее получения
Zhao et al. Preparation and efficacy of a live newcastle disease virus vaccine encapsulated in chitosan nanoparticles
Calderon-Nieva et al. Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals
US20230173058A1 (en) Sars-cov-2 vaccine
KR20040073438A (ko) 입자 형태의 약제학적 조성물
Fawzy et al. Nanoparticles as a novel and promising antiviral platform in veterinary medicine
Huyge et al. Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry
CN103687942A (zh) 病毒样颗粒及其制备方法
Garmise et al. Dry powder nasal vaccines as an alternative to needle-based delivery
Corbanie et al. Vaccination of broiler chickens with dispersed dry powder vaccines as an alternative for liquid spray and aerosol vaccination
CN109045291B (zh) 一种猪支原体肺炎气溶胶活疫苗及其制备方法
US20260014251A1 (en) Compositions, methods, and uses for polynucleotide formulations for drying and prolonged storage
JPWO2019021957A1 (ja) 点鼻用乾燥粉末医薬組成物
Shawky et al. Comparative protective efficiency of different stabilizers for live Newcastle Disease Virus vaccine production
TWI267553B (en) An avian embryo particulate biomass for the production of antigens
US20070098740A1 (en) Stabilisation of viral microparticles
WO2026102484A1 (en) Paramyxovirus combination vaccine
WO2026102483A1 (en) Newcastle disease virus vaccine
AU2003264166A1 (en) Improvements in or relating to vaccines
WO2012125658A1 (en) Aerosolized thermostable granular particulate vaccine preparation
Corbanie et al. VACCINATION OF CHICKENS WITH DRY POWDER VACCINES AS AN ALTERNATIVE TO LIQUID SPRAY AND AEROSOL VACCINATION
Hellfritzsch ZINC OXIDE IN FORMULATION

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: J.P.Lemmon

Inventor after: Vervaet Chris

Inventor after: Corbanie Evy

Inventor after: J, H, H von AIKE

Inventor after: W, J, M, Rand

Inventor before: J.P.Lemmon

Inventor before: Vervaet Chris

Inventor before: Corbanie Evy

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: REMON JEAN PAUL C. VERVAET CORBANIE EVY TO: REMON JEAN PAUL C. VERVAET CORBANIE EVY J. H. H. VON IKE W. J. M. LANDMAN

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20090422